Wednesday Oct 29, 2025
Wednesday, 29 October 2025 01:21 - - {{hitsCtrl.values.hits}}

Nawaloka Hospitals PLC has reported a net profit of Rs. 56 million for the financial year ended 31 March 2025, marking a strong turnaround from the Rs. 305 million loss recorded in the previous year.
The Group’s revenue increased by 6% to Rs. 11.0 billion, supported by growth in patient volumes, medical tourism, and technology-driven service improvements. Gross profit rose to Rs. 5.8 billion, while total comprehensive income reached Rs. 327 million.
![]() |
| Chairman Dr. Jayantha Dharmadasa |
Company officials attributed the positive results to tighter cost management, strategic investments in digital health systems, and increased demand for specialised care.
Following the close of the financial year, Nawaloka Hospitals successfully concluded a debt settlement with Hatton National Bank PLC. While not reflected in the reported accounts, this step has significantly strengthened the Group’s balance sheet and improved liquidity.
Investor confidence has been evident, with Nawaloka’s share price climbing from Rs. 3.90 in March 2024 to Rs. 8.00 in September 2025, more than doubling the Group’s market capitalisation to Rs. 11.3 billion.
This recovery coincides with Nawaloka’s 40th anniversary milestone. Established in 1985, the Group has grown into one of Sri Lanka’s largest private healthcare providers, with operations spanning diagnostics, outpatient services, and medical education.
During the year, Nawaloka Hospitals marked several significant milestones that reinforced its position as a pioneer in Sri Lanka’s healthcare sector. The Group launched South Asia’s first AI-powered Radiology Centre and expanded its portfolio of AI-driven medical evaluation services, setting new benchmarks in advanced diagnostics. These innovations earned Nawaloka the prestigious title of “Leading Hospital in AI & Innovation – Asia Pacific 2025” at the Global Health Asia Pacific Summit in Bangkok, while further recognition at the National Business Excellence Awards underscored its continued leadership and contribution to the country’s healthcare industry.
Chairman and CEO Dr. Jayantha Dharmadasa said: “These results reflect renewed financial resilience and a stronger foundation to pursue long-term growth. As we mark four decades of service, our achievements are a testament to the dedication of our staff and the enduring trust placed in us by patients. We remain committed to advancing healthcare standards in Sri Lanka through innovation and excellence.”